[Abstract] Efficient delivery of oligonucleotide therapeutics, i.e., siRNAs, to the central nervous system represents a significant barrier to their clinical advancement for the treatment of neurological disorders.
RNAs between cells over short and long distances, thus playing a crucial role in health and disease (Distler et Though both strategies have been able to promote the transfer of siRNA-loaded extracellular vesicles into target cells and the silencing of the target gene, they cannot be controlled or scaled up for clinical-stage manufacturing (Kooijmans et al., 2013) . Moreover, electroporation compromises the integrity of extracellular vesicles (Kooijmans et al., 2013) . We demonstrated the efficient loading of extracellular vesicles with hsiRNAs without modifying the vesicle size distribution, concentration and integrity. hsiRNA-loaded extracellular vesicles were shown to induce gene silencing of the target gene, huntingtin mRNA, in vitro in mouse primary neurons, and in vivo in mouse brain (Didiot et al., 2016) .
Here, we describe a method exploring the ability of hsiRNAs to bind membranes to promote their loading into extracellular vesicles. The co-incubation of hsiRNAs with extracellular vesicles purified from cell culture conditioned medium, promotes loading into extracellular vesicles. We provide details a. The purification of extracellular vesicles is shown in Figure 1 . 
ii. In vivo experiments need a significant concentration of extracellular vesicles for efficient
www.bio-protocol.org/e2338 a. In multilayer flasks, grow adherent cells of interest in the regular recommended medium until they reach 70% to 80% confluency. We observed that 60 ml is the minimal volume of medium that can be used in T500 cm 2 triple flask.
b. Pour the culture medium in a liquid trash, as serological pipette cannot be used to remove liquid from multilayer flasks. Using a 50 ml serological pipette, replace the medium with a similar volume of recommended EV-depleted medium.
c. Incubate the cells for 48 h at 37 °C, 5% CO2 and 100% humidity.
d. Collect the medium and proceed to extracellular vesicle purification as followed. If the cells are not 100% confluent, replace the collected medium with fresh extracellular vesicle-depleted medium, incubate for 48 h and repeat the extracellular vesicle purification as followed.
e. Harvest the culture medium containing extracellular vesicles in 50 ml centrifuge conical tubes.
f. Centrifuge at 300 x g for 10 min at room temperature to pellet and eliminate the floating cells and large debris.
g. Transfer the supernatant into new 50 ml centrifuge conical tubes using 50 ml serological pipette. Leave 2-3 ml of medium in the bottom of the tube to avoid disturbing the pellet.
Discard the pellet.
h. Centrifuge the supernatant at 10,000 x g, 4 °C for 30 min to isolate large vesicles or microvesicles.
i. Pour and filter sterilize the supernatant through a vacuum-connected sterile 0.22 μm filter unit to further eliminate larger vesicles. i. To anneal the PNA strands to the hsiRNA guide strands, incubate for 15 min at 95 °C (to melt hsiRNA duplexes) followed by an incubation at 50 °C (to anneal PNA to hsiRNA guide strands, replacing sense strands) for 15 min and cool to room temperature.
j. Transfer the samples in a 96-well plate or in vials compatible with your HPLC system. k. Inject the samples containing PNA-hsiRNA guide strand hybrids into HPLC anion exchange column, automatically using an autosampler or manually using a Hamilton syringe. The buffer A and buffer B used for the mobile phase are described in the Recipes section.
Optimize the speed of gradient between 10% buffer B to 100% buffer B according to your HPLC system and anion exchange column. An example of protocol is described in Table 1 .
The elution time will be determined by the negative charge of the hsiRNA guide strands and not influenced by the neutral PNA. 
Characterization of extracellular vesicles size distribution and concentration
For each sample, the concentration and size of vesicles are determined by recording and analyzing the Brownian motion of particles in PBS and using a NanoSight NS300 system and a Nanoparticles Tracking Analysis (NTA) software (see Note 8).
a. Dilute 1 to 5 µl of sample in 1 ml PBS (dilution ratio 1:200 to 1:1,000) at room temperature in a 1.5 ml microtube and mix gently using 1 ml micropipette.
b. Inject the diluted sample in the NanoSight NS300 system using a 1 ml syringe. 
Characterization of extracellular vesicles surface charge
The hsiRNA-EV surface charges are determined by Laser Doppler Micro-electrophoresis (DLM) using a Zetasizer Nano. The particles charge is obtained by applying an electric field on the sample and measuring the velocity of the particles present in the sample. The surface charge of the particles is directly correlated to their velocity.
a. Dilute 1 to 5 µl of sample in 1 ml distilled H2O (dilution ratio 1:200 to 1:1,000) at room temperature in a 1.5 ml microtube and mix gently using 1 ml micropipette. We noticed that www.bio-protocol.org/e2338 e. Monitor the sample charges in duplicate.
f. The instrument gives an absolute value of the particles charge. We observed that hsiRNA-loaded extracellular vesicles have more negative charges than non-loaded extracellular vesicles.
6. Analysis of extracellular vesicles and hsiRNA-loaded extracellular vesicles integrity by electron microscopy.
To detect hsiRNAs bound to extracellular vesicles by electron microscopy, we use biotinylated hsiRNA and streptavidin immune-gold particles. Samples and grids used for electron microscopy are prepared at room temperature unless otherwise specified. e. Transfer the grid to a 100 µl drop of 50 mM glycine/PBS and incubate for 5 min.
f. Transfer the grid to a 100 µl drop of 5% BSA/PBS for 10 min to block the sample. 6. In the mouse heart, still beating, place a needle connected to the peristaltic pump to infuse room temperature PBS for 5 min to remove the blood from the brain. 
Data analysis
Data are processed using Microsoft Office Excel and analyzed using GraphPad Prism 6 software.
The levels of targeted and housekeeping genes in the biopsies are independently measured using the QuantiGene ® bDNA assay. The average of the 3 technical replicates represents the mRNA expression value per animal (see Notes 12 and 13). 11. hsiRNA-loaded extracellular vesicles are stable and loaded hsiRNAs are resistant to nucleases.
However, only a fraction of the loaded hsiRNA is internalized into the vesicle lumen, and another fraction associates to the outer membrane. At this point, we cannot define which of the extracellular vesicles-associated oligonucleotides (surface bound or internalized) are functionally active. Further studies are essential to determine the optimal loading, long-term stability, and in vivo behavior of the hsiRNA-loaded extracellular vesicles.
12. Based on preliminary data, the level of target mRNA expression variation from animal to animal has ~15% error, which theoretically requires n = 8 animals to be able to detect 20-30% gene modulation with 80% confidence. For in vivo validation of hsiRNA-extracellular vesicles sample efficacy using pump-based infusion, the mice groups are powered with n = 8 to n = 10 mice.
13. The pump implantation requires extensive surgery that can result in uncontrolled animal death during the procedure and account for the difference in number of animals for different groups.
Recipes
Note: For all recipes and at any step of the procedure use Milli-Q-purified water.
Cell culture medium
Note: Recommended culture medium supplemented with FBS and antibiotics. 
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